About Us – Your Trusted Partner in CAR-T Therapy

Dedicated to providing professional CAR-T cell medical services and treatment solutions for international patients with hematologic malignancies.

Specialized Car-t treatment for hematological diseases

Who We Are?

SinoTcell is a premier medical service platform dedicated to bridging the gap between global patients and China’s world-leading CAR-T cell therapy.

Our Mission：
Navigating foreign medical systems can be daunting. We leverage our extensive industry knowledge and CHIMA-certified expertise to dismantle language, cultural, and informational barriers.

Our Mission Is Simple:
To provide a transparent, expert-led gateway for international patients to access world-class treatment in China. We believe that life-saving medical excellence should be accessible to everyone, regardless of borders.

OUR TEAM

Our experts

Led by a team of professionals with over 10 years of experience in international healthcare, our foundation is built on deep-rooted clinical expertise. Our founder’s background within China’s top-tier hospitals provides an unparalleled “insider’s perspective” on the complex Chinese medical landscape—an advantage that ensures our patients receive the most direct and effective coordination.

梁英民教授

西安国际医学中心血液病医院院长

李国辉

西安国际医学中心医院血液三病区主任

黄斯勇

西安国际医学中心医院血液一病区主任

杨莉洁

西安国际医学中心血液病院骨髓移植病区、血液二病区主任

郝彩霞

血液二病区副主任，医院硕士

王刚锋

实验中心副主任

李艳春

实验中心副主任

Authoritatively Certified Hospital

Our Professional Advantages

We have obtained international JCI accreditation and have passed China’s Class III Grade A (Top-Tier) hospital evaluation. We are also certified with GCP (Good Clinical Practice) qualifications for clinical trials.

In addition, we have undertaken more than 20 provincial- and national-level research projects in China, published over 160 SCI-indexed and authoritative academic papers, and hold more than 10 patents. Multiple research achievements have already been applied in clinical practice.

Professional Medical Team

Our medical advisory team consists of senior experts in hematology, oncology, and immunotherapy. They possess extensive clinical experience and strong academic expertise in the field of CAR-T therapy.

Comprehensive End-to-End Service System

From initial consultation and medical record evaluation to treatment planning, medical visa assistance, travel arrangements to China, inpatient support, and post-treatment follow-up, we provide a comprehensive one-stop, end-to-end service.

Multilingual Service Support

We provide services in multiple languages, including English, Chinese, Japanese, Korean, and Thai, ensuring smooth and seamless communication between patients and the medical team.

Xi’an International Medical Center Hospital · Hematology Hospital Introduction

Established in November 2019, passed JCI international accreditation in 2021, passed the Grade A tertiary hospital evaluation in 2025, and obtained GCP clinical trial qualifications.
Selected in 2024 as a key specialty construction unit of Shaanxi Province.
The core team comes from the Fourth Military Medical University and top domestic Grade A tertiary hospitals, possessing rich clinical and research experience.
The medical team consists of 89 members: 35 physicians (including 5 with senior professional titles), 40 nursing staff, and 13 medical technicians.
Specialized wards are established for leukemia, lymphoma, myeloma, hematopoietic stem cell transplantation, and other specialties.
The diagnostic center includes six major laboratories (cell morphology, genetics, immunology, molecular biology, cell therapy, and quality control), and is one of the leading precision diagnosis platforms for hematologic diseases in western China.
Undertakes more than 20 national and provincial research projects, has published more than 160 SCI and authoritative papers, holds more than 10 patents, and multiple achievements have been applied clinically.

Specialized Car-t treatment for hematological diseases

Our Qualifications and Certifications

Hospitals all possess National Health Commission–approved CAR-T treatment qualifications,have passed JCI international healthcare accreditation,comply with international healthcare quality standards.
All members of the medical team hold Chinese physician qualification certificates, multiple experts hold important positions in the International Society of Hematology and the Asian Society of Hematology.
We strictly adhere to international medical ethics standards, protect patient privacy, ensure the transparency and safety of the treatment process.

Contact us today to receive a free CAR-T therapy eligibility assessment. Our expert team will respond to your inquiry within 12 hours.

Why Choose Us?

Professional and Reliable: Focused on the field of CAR-T therapy, with extensive experience in serving international patients.
Medical Advantages: Connected with China’s top CAR-T treatment centers, providing access to the latest treatment technologies.
Cost-Effectiveness: Compared with Europe and the United States, the cost of CAR-T treatment in China is more competitive.
Full accompaniment: from consultation to recovery, the professional team accompanies you throughout the whole process, letting you have no worries at all.